• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺叶袖状切除术后非小细胞肺癌患者拟用的残余肿瘤分类的预后意义

Prognostic Significance of the Proposed Residual Tumor Classification in Patients With NSCLC After Sleeve Lobectomy.

作者信息

Chen Tao, Zhong Yifan, Wen Jialiang, Deng Jiajun, She Yunlang, Zhu Yuming, Chen Qiankun, Wu Chunyan, Hou Likun, Jiang Lei, Chen Chang

机构信息

Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.

Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.

出版信息

JTO Clin Res Rep. 2023 Sep 14;4(10):100574. doi: 10.1016/j.jtocrr.2023.100574. eCollection 2023 Oct.

DOI:10.1016/j.jtocrr.2023.100574
PMID:37822700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10563046/
Abstract

INTRODUCTION

To validate the residual tumor (R) classification proposed by the International Association for the Study of Lung Cancer (IASLC) in NSCLC after sleeve lobectomy.

METHODS

A total of 682 patients were analyzed. The R status, on the basis of the Union for International Cancer Control (UICC) criteria, was recategorized according to the IASLC descriptors. Recurrence-free survival (RFS) and overall survival (OS) among different R classifications were assessed for the entire cohort and pathologic node (pN) subgroups.

RESULTS

All in all, 631 (92.5%), 48 (7.1%), and three patients (0.4%) were classified as R0, R1, and R2, respectively, by the UICC criteria, whereas 489 (71.7%), 110 (16.1%), and 83 patients (12.2%), received R0, uncertain resection (R[un]), and R1/2 resection, respectively, according to the IASLC criteria. There were 96 patients (15.2%) with UICC R0 who were reclassified as R(un), mainly because of the positive highest mediastinal node station (82 of 96, 85.4%). A total of 46 patients (7.3%) were reassigned from UICC R0 to IASLC R1/2 owing to extracapsular extension. For the entire cohort, patients with R(un) and R1/2 exhibited worse RFS (R[un], adjusted  = 0.023; R1/2, adjusted  = 0.001) and OS (R[un], adjusted  = 0.040; R1/2, adjusted  = 0.051) compared with R0. No significant differences were observed between R(un) and R1/2 (RFS, adjusted  = 0.586; OS, adjusted  = 0.781). Furthermore, subgroup analysis revealed a distinct prognostic impact of the IASLC R status-with prognostic significances in the pN1 and pN2 subgroups, but not in the pN0 subgroup.

CONCLUSIONS

The IASLC R descriptors helped to stratify the prognosis of NSCLC after sleeve lobectomy, with its prognostic impact varied among pN stages.

摘要

引言

验证国际肺癌研究协会(IASLC)提出的非小细胞肺癌(NSCLC)袖式肺叶切除术后残留肿瘤(R)分类。

方法

共分析682例患者。根据国际癌症控制联盟(UICC)标准确定的R状态,按照IASLC的描述重新分类。评估整个队列以及病理淋巴结(pN)亚组中不同R分类的无复发生存期(RFS)和总生存期(OS)。

结果

总体而言,根据UICC标准,分别有631例(92.5%)、48例(7.1%)和3例患者(0.4%)被分类为R0、R1和R2,而根据IASLC标准,分别有489例(71.7%)、110例(16.1%)和83例患者(12.2%)接受了R0、不确定切除(R[un])和R1/2切除。有96例(15.2%)UICC R0患者被重新分类为R(un),主要原因是最高纵隔淋巴结站阳性(96例中的82例,85.4%)。共有46例(7.3%)患者因包膜外侵犯从UICC R0重新分类为IASLC R1/2。对于整个队列,与R0相比,R(un)和R1/2患者的RFS(R[un],校正后=0.023;R1/2,校正后=0.001)和OS(R[un],校正后=0.040;R1/2,校正后=0.051)较差。R(un)和R1/2之间未观察到显著差异(RFS,校正后=0.586;OS,校正后=0.781)。此外,亚组分析显示IASLC R状态具有明显的预后影响——在pN1和pN2亚组中有预后意义,但在pN0亚组中没有。

结论

IASLC的R描述有助于对NSCLC袖式肺叶切除术后的预后进行分层,其预后影响在pN分期中有所不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a51/10563046/a7a42328ab83/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a51/10563046/919e59304610/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a51/10563046/db81e925297e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a51/10563046/ffac715d023e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a51/10563046/a7a42328ab83/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a51/10563046/919e59304610/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a51/10563046/db81e925297e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a51/10563046/ffac715d023e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a51/10563046/a7a42328ab83/gr4.jpg

相似文献

1
Prognostic Significance of the Proposed Residual Tumor Classification in Patients With NSCLC After Sleeve Lobectomy.肺叶袖状切除术后非小细胞肺癌患者拟用的残余肿瘤分类的预后意义
JTO Clin Res Rep. 2023 Sep 14;4(10):100574. doi: 10.1016/j.jtocrr.2023.100574. eCollection 2023 Oct.
2
A Validation Study of the Recommended Change in Residual Tumor Descriptors Proposed by the International Association for the Study of Lung Cancer for Patients With pN2 NSCLC.国际肺癌研究协会建议的 pN2 NSCLC 患者残余肿瘤标志物推荐改变的验证研究。
J Thorac Oncol. 2021 May;16(5):817-826. doi: 10.1016/j.jtho.2021.01.1621. Epub 2021 Feb 16.
3
Residual tumor descriptors proposed by the International Association for the Study of Lung Cancer may not be applicable to stage I and ground-glass opacity-featured non-small cell lung cancer.国际肺癌研究协会提出的残留肿瘤描述符可能不适用于I期和以磨玻璃影为特征的非小细胞肺癌。
Transl Lung Cancer Res. 2023 Nov 30;12(11):2157-2168. doi: 10.21037/tlcr-23-497. Epub 2023 Nov 20.
4
Validation of the IASLC Residual Tumor Classification in Patients With Stage III-N2 Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiotherapy Followed By Surgery.IASLC 残留肿瘤分类在接受新辅助放化疗后手术的 III-N2 期非小细胞肺癌患者中的验证。
Ann Surg. 2023 Jun 1;277(6):e1355-e1363. doi: 10.1097/SLA.0000000000005414. Epub 2022 Feb 15.
5
The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer.IASLC 肺癌分期项目:非小细胞肺癌切缘状态分析及残余肿瘤描述符建议。
J Thorac Oncol. 2020 Mar;15(3):344-359. doi: 10.1016/j.jtho.2019.10.019. Epub 2019 Nov 13.
6
Prognostic evaluation of the proposed residual tumor classification in a Chinese non-small cell lung cancer population.在中国非小细胞肺癌人群中对提出的残余肿瘤分类的预后评估。
J Surg Oncol. 2022 May;125(6):1061-1070. doi: 10.1002/jso.26810. Epub 2022 Jan 31.
7
Recurrence Dynamics of Pathological N2 Non-Small Cell Lung Cancer Based on IASLC Residual Tumor Descriptor.基于国际肺癌研究协会(IASLC)残留肿瘤描述符的病理性N2非小细胞肺癌复发动态
Cancer Res Treat. 2025 Jan;57(1):105-115. doi: 10.4143/crt.2024.150. Epub 2024 Jul 23.
8
Beyond Margin Status: Population-Based Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification Recategorization.切缘状态之外:国际肺癌研究协会残余肿瘤分类重新分类的基于人群验证。
J Thorac Oncol. 2020 Mar;15(3):371-382. doi: 10.1016/j.jtho.2019.11.009. Epub 2019 Nov 26.
9
Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification to Upgrade Extracapsular Extension of Tumor in Nodes From R0 to Incomplete Resection.验证国际肺癌研究协会提出的肿瘤残瘤分类,以将 R0 切缘的淋巴结包膜外侵犯升级为不完全切除。
J Thorac Oncol. 2024 Jan;19(1):130-140. doi: 10.1016/j.jtho.2023.08.003. Epub 2023 Aug 9.
10
Prognostic Value of Uncertain Resection for Overall Survival in Non-small Cell Lung Cancer.不确定切除对非小细胞肺癌总生存预后的价值。
Ann Thorac Surg. 2022 Oct;114(4):1262-1268. doi: 10.1016/j.athoracsur.2021.07.087. Epub 2021 Aug 30.

引用本文的文献

1
The IASLC uncertain resection, general overview, current evidence, and future prospects: a systematic review and meta-analysis.国际肺癌研究协会(IASLC)对不确定切除的概述、当前证据及未来展望:一项系统评价和荟萃分析
Ther Adv Med Oncol. 2025 Jul 15;17:17588359251344789. doi: 10.1177/17588359251344789. eCollection 2025.
2
Uncertain Resection in Lung Cancer: A Comprehensive Review of the International Association for the Study of Lung Cancer Classification.肺癌的不确定切除:国际肺癌研究协会分类的综合综述
Cancers (Basel). 2025 Apr 22;17(9):1386. doi: 10.3390/cancers17091386.

本文引用的文献

1
Reclassifying the International Association for the Study of Lung Cancer Residual Tumor Classification According to the Extent of Nodal Dissection for NSCLC: One Size Does Not Fit All.根据 NSCLC 淋巴结清扫范围对国际肺癌研究协会残余肿瘤分类进行重新分类:一刀切并不适合所有情况。
J Thorac Oncol. 2022 Jul;17(7):890-899. doi: 10.1016/j.jtho.2022.03.015. Epub 2022 Apr 21.
2
Comparison of uniportal video-assisted thoracoscopic versus thoracotomy bronchial sleeve lobectomy with pulmonary arterioplasty for centrally located non-small-cell lung cancer.单孔电视辅助胸腔镜与剖胸支气管袖状肺叶切除术联合肺动脉成形术治疗中央型非小细胞肺癌的比较。
Eur J Cardiothorac Surg. 2021 May 8;59(5):978-986. doi: 10.1093/ejcts/ezaa404.
3
Comparison of Bronchial Sleeve Lobectomy With Pulmonary Arterioplasty Versus Pneumonectomy.
支气管袖状肺叶切除术与肺动脉成形术与肺切除术的比较。
Ann Thorac Surg. 2022 Mar;113(3):934-941. doi: 10.1016/j.athoracsur.2021.04.007. Epub 2021 Apr 16.
4
A Validation Study of the Recommended Change in Residual Tumor Descriptors Proposed by the International Association for the Study of Lung Cancer for Patients With pN2 NSCLC.国际肺癌研究协会建议的 pN2 NSCLC 患者残余肿瘤标志物推荐改变的验证研究。
J Thorac Oncol. 2021 May;16(5):817-826. doi: 10.1016/j.jtho.2021.01.1621. Epub 2021 Feb 16.
5
Characterization of Extracapsular Lymph Node Involvement and Its Clinicopathological Characteristics in Stage II-IIIA Lung Adenocarcinoma.II-IIIA期肺腺癌的囊外淋巴结受累特征及其临床病理特征
Ann Surg Oncol. 2021 Apr;28(4):2088-2098. doi: 10.1245/s10434-020-09154-6. Epub 2020 Oct 4.
6
Comparison of video-assisted thoracoscopic surgery with thoracotomy in bronchial sleeve lobectomy for centrally located non-small cell lung cancer.视频辅助胸腔镜手术与开胸手术治疗中央型非小细胞肺癌支气管袖状肺叶切除术的比较。
J Thorac Cardiovasc Surg. 2021 Feb;161(2):403-413.e2. doi: 10.1016/j.jtcvs.2020.01.105. Epub 2020 Mar 25.
7
Clinical outcomes of microscopic residual disease after bronchial sleeve resection for non-small cell lung cancer.非小细胞肺癌支气管袖状切除术后微小残留病灶的临床结局
J Thorac Cardiovasc Surg. 2020 Feb 29. doi: 10.1016/j.jtcvs.2020.02.079.
8
Beyond Margin Status: Population-Based Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification Recategorization.切缘状态之外:国际肺癌研究协会残余肿瘤分类重新分类的基于人群验证。
J Thorac Oncol. 2020 Mar;15(3):371-382. doi: 10.1016/j.jtho.2019.11.009. Epub 2019 Nov 26.
9
The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer.IASLC 肺癌分期项目:非小细胞肺癌切缘状态分析及残余肿瘤描述符建议。
J Thorac Oncol. 2020 Mar;15(3):344-359. doi: 10.1016/j.jtho.2019.10.019. Epub 2019 Nov 13.
10
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis.结外转移是影响非小细胞肺癌预后的不良因素:一项荟萃分析。
Virchows Arch. 2018 Jun;472(6):939-947. doi: 10.1007/s00428-018-2309-1. Epub 2018 Feb 1.